Drug News

Medindia's Press Release’ section provides the latest press release on Drug from across the world for the global audience. This page links to 12872 Drug press releases.

Happy Fruit Redefines Wellness with THCV-Infused Gummies: A Breakthrough in Cannabinoid Innovation and Metabolic Supplements

Unlocking the Power of THCV: Happy Fruit's New Gummies Suppress Appetites and Provide Metabolic Support * OCEANSIDE, Calif. , April 18, 2024 /PRNewswire/ -- Happy Fruit ,  renowned for its delicious and nutritious fruit ...


41st International Conference on Drug Discovery and Drug delivery system

On behalf of the organizing committee its great pleasure to invite to all attendees of the "41st International Conference on Drug Discovery and Drug Delivery System" taking place on November 28-29 2024 in the enchanting city of Paris France. With ...

London Research & Pharmaceuticals presents the Advancement of LRP-661, their Oral Cannabidiol Sulphate Drug Candidate at the Prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII Conference in Miami

LONDON, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- London Research & Pharmaceuticals has recently publicized data about its lead compound LRP-661 or Cannabidiol sulphate (CBDS), highlighting its safety, efficacy, bioavailability, and ...

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection

Provides MarVax™ Heat Stable Vaccine Seven Years of U.S. Market Exclusivity Upon FDA Approval  PRINCETON, N.J. , April 15, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage ...

SparX Group Announces First Patient Dosed with SPX-303 Injection, the First in Its Class of anti-LILRB2/PD-L1 Bispecific Antibody Drugs

CHICAGO , April 11, 2024 /PRNewswire/ -- Signifying a monumental step forward in the domain of powered antibody therapies, SparX is thrilled to announce that the first patient has been successfully dosed with SPX-303, a First-in-Class ...

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection

Provides SuVax™   Heat Stable Vaccine Seven Years of U.S. Market Exclusivity Upon FDA Approval PRINCETON, N.J. , April 11, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage ...

Sen-Jam Pharmaceutical Partners with Specialty Pharmaceutical Manufacturer to Provide Formulation and Chemistry, Manufacturing & Controls for Revolutionary Anti-Inflammatory Injectable

Sen-Jam Pharmaceutical has entered their third development, manufacturing, distribution and license agreement with KVK-Tech. This is a monumental milestone for the company and great news for their promising multi-use anti-inflammatory ...

BioCity Announces FDA Clearance of the Investigational New Drug Application for its First-In-Class Antibody Drug Conjugate Targeting Glypican 3

SHANGHAI , April 9, 2024 /PRNewswire/ -- BioCity Biopharma today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for a Phase 1 study of BC2027. BC2027, which ...

Shield Your Herd: University Products Leads the Charge with Premier Bovine Anaplasmosis Vaccine

BATON ROUGE, La. , April 9, 2024 /PRNewswire/ -- As Anaplasmosis continues to extend its infectious reach beyond the southeastern United States , University Products remains at the forefront of defense. Traditionally confined to certain ...

Transcenta Announces Collaboration with Agilent to Develop a Claudin18.2 Companion Diagnostic to Support Osemitamab (TST001) Global Phase III Trial

PRINCETON, N.J. and SUZHOU, China , April 8, 2024 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, ...

Drug News »

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Biopharmaceutical companies are once again competing in the development of innovative drugs for metabolic dysfunction-associated steatohepatitis (MASH), after a series of failures faced by drug manufacturers. The US FDA approval of ...

Semaglutide: A Dominant Player for Patients With Heart Failure

Semaglutide: A Dominant Player for Patients With Heart Failure

A study was presented by the Gardy Health system in Atlanta, Georgia, US, at the 73rd Annual Scientific Session of the American College of Cardiology. The study was conducted to evaluate the frequency of heart failure hospitalizations (HFH) in ...

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Generic drugs and Branded drugs are essentially the same, as they both have the same active ingredient. Generic drugs can provide the same therapeutic advantages as branded drugs at a reduced cost, as they do not have to undergo extensive ...

Drug Resistant Melanoma Caused Due to Break in Genes!

Drug Resistant Melanoma Caused Due to Break in Genes!

Melanoma is an extremely fatal form of skin cancer and has inherent resistance to both radiotherapy and chemotherapy ( ). The occurrence of Melanoma has been increasing steadily and become a major health issue since the 5-year ...

Marijuana Use for Morning Sickness Risks Mother and Baby Health

Marijuana Use for Morning Sickness Risks Mother and Baby Health

Using marijuana to alleviate nausea and vomiting during pregnancy could harm newborns’ brain development and exacerbate maternal health issues ...

More Drug News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.